- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 51.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.07M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.76M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.37M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $150K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $150K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $17.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.56M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.82M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.77M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.21M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.09M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.91M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.79M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.15M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.65 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.65 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.10 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $235.53K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $86.66K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.02M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.42M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.91M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.06M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $68.62K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $17.72K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $45.16K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $45.16K |
| Revenue | Q1 2026 · Mar 31, 2026 | $113.77K |
| Revenue | Q1 2026 · Mar 31, 2025 | $62.87K |